1. Home
  2. GKOS vs HBM Comparison

GKOS vs HBM Comparison

Compare GKOS & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • HBM
  • Stock Information
  • Founded
  • GKOS 1998
  • HBM 1927
  • Country
  • GKOS United States
  • HBM Canada
  • Employees
  • GKOS N/A
  • HBM N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • HBM Metal Mining
  • Sector
  • GKOS Health Care
  • HBM Basic Materials
  • Exchange
  • GKOS Nasdaq
  • HBM Nasdaq
  • Market Cap
  • GKOS 5.8B
  • HBM 4.6B
  • IPO Year
  • GKOS 2015
  • HBM N/A
  • Fundamental
  • Price
  • GKOS $94.00
  • HBM $12.74
  • Analyst Decision
  • GKOS Strong Buy
  • HBM
  • Analyst Count
  • GKOS 12
  • HBM 0
  • Target Price
  • GKOS $131.17
  • HBM N/A
  • AVG Volume (30 Days)
  • GKOS 693.4K
  • HBM 7.0M
  • Earning Date
  • GKOS 11-03-2025
  • HBM 08-13-2025
  • Dividend Yield
  • GKOS N/A
  • HBM 0.14%
  • EPS Growth
  • GKOS N/A
  • HBM 216.33
  • EPS
  • GKOS N/A
  • HBM 0.72
  • Revenue
  • GKOS $432,953,000.00
  • HBM $2,202,000,000.00
  • Revenue This Year
  • GKOS $28.79
  • HBM $13.55
  • Revenue Next Year
  • GKOS $25.65
  • HBM N/A
  • P/E Ratio
  • GKOS N/A
  • HBM $17.14
  • Revenue Growth
  • GKOS 26.70
  • HBM 8.31
  • 52 Week Low
  • GKOS $77.10
  • HBM $5.95
  • 52 Week High
  • GKOS $163.71
  • HBM $12.47
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.08
  • HBM 76.39
  • Support Level
  • GKOS $89.83
  • HBM $11.62
  • Resistance Level
  • GKOS $97.00
  • HBM $12.47
  • Average True Range (ATR)
  • GKOS 2.65
  • HBM 0.31
  • MACD
  • GKOS 0.39
  • HBM 0.12
  • Stochastic Oscillator
  • GKOS 71.27
  • HBM 97.77

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About HBM Hudbay Minerals Inc. (Canada)

Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.

Share on Social Networks: